The FDA granted fast track designation for CTx001, an investigational gene therapy candidate for geographic atrophy secondary ...

The US Food and Drug Administration (FDA) has granted Fast Track Designation to Complement Therapeutics’ CTx001, the ...

Scientists at USC are launching a new trial to test a tiny stem cell implant that could restore vision in people with ...

Thanks to this tiny piece of tech, people with profound vision loss can now read, do cross word puzzles, and navigate public ...

Aviceda Therapeutics has hit a snag in its goal to deliver a new treatment for geographic atrophy (GA), an advanced form of dry age-related macular degeneration. The biotech’s lead asset, AVD-104, ...

Hemodialysis significantly alters anterior and posterior eye segments, affecting parameters like anterior chamber depth, lens ...

Age-related macular degeneration, the leading cause of vision loss and blindness for Americans 65 and older, is a progressive disease affecting central vision. Over time, faces, book pages and ...

Geographic Atrophy (GA) is an advanced form of age-related macular degeneration (AMD) that results in progressive and irreversible vision loss, particularly in older adults. It occurs due to the ...

A study supported the ellipsoid zone loss as a meaningful biomarker that can be used to guide clinical trial design in ...

Armed with a recent authorization from the FDA, eye specialists are offering light therapy to patients with non-exudative (dry) age-related macular degeneration (AMD), aiming to stop or even reverse ...

Dr. Patrick Staropoli will compete full-time in the 2026 NASCAR O’Reilly Auto Parts Series with Big Machine Racing. The team confirmed he will drive the No. 48 SYFOVRE Chevrolet starting with the ...